Anna M Eiring

15PUBLICATIONS
27CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 28, 2026
Autophagy and Lipid Metabolism as a Therapeutic Target for Overcoming Drug Resistance in Acute Myeloid Leukemia.

Seyed Mohammadreza Bolandi, Mahdi Pakjoo, Briandy Fernandez-Marrero

|Mar 12, 2024
Facility type and cancer outcomes in the United States.

Michelle Kilcoyne, Vutha Nhim, Mayra A Gonzalez

|Dec 19, 2022
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.

Mayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez

|Dec 11, 2022
19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML).

Joshua J Lara, Alfonso E Bencomo-Alvarez, Mayra A Gonzalez

|May 28, 2022
Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics.

Ilene Le, Subramanian Dhandayuthapani, Jessica Chacon

|Nov 27, 2021
A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia.

Seyed Mohammadreza Bolandi, Mahdi Pakjoo, Peyman Beigi

Pageof 3

Frequent Collaborators

3 joint publications

Michael W Deininger

3 joint publications

Brian J Druker

3 joint publications

Jamshid Sorouri Khorashad

2 joint publications

Andres J Rubio